Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
21.57
+0.04 (0.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $323.58 million as of December 20, 2024. Its market cap has increased by 457.60% in one year.
Market Cap
323.58M
Enterprise Value
233.15M
1-Year Change
457.60%
Ranking
Category
Stock Price
$21.57
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has increased from $122.75M to $323.58M, an increase of 163.61%. That is a compound annual growth rate of 21.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 323.58M | 267.57% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Olema Pharmaceuticals | 331.52M |
| Neurogene | 327.34M |
| Corvus Pharmaceuticals | 327.07M |
| Candel Therapeutics | 323.46M |
| Acelyrin | 323.05M |
| Revance Therapeutics | 322.05M |
| Trevi Therapeutics | 318.99M |
| AirSculpt Technologies | 317.77M |